IN2013MN00758A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN00758A IN2013MN00758A IN758MUN2013A IN2013MN00758A IN 2013MN00758 A IN2013MN00758 A IN 2013MN00758A IN 758MUN2013 A IN758MUN2013 A IN 758MUN2013A IN 2013MN00758 A IN2013MN00758 A IN 2013MN00758A
- Authority
- IN
- India
- Prior art keywords
- therapeutic agent
- devices
- implants
- antibodies
- months
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40893410P | 2010-11-01 | 2010-11-01 | |
US201161470299P | 2011-03-31 | 2011-03-31 | |
PCT/US2011/058774 WO2012061377A1 (en) | 2010-11-01 | 2011-11-01 | Bioerodible silicon-based devices for delivery of therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MN00758A true IN2013MN00758A (es) | 2015-06-12 |
Family
ID=46024803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN758MUN2013 IN2013MN00758A (es) | 2010-11-01 | 2011-11-01 |
Country Status (11)
Country | Link |
---|---|
US (3) | US9333173B2 (es) |
EP (1) | EP2635255B1 (es) |
JP (2) | JP6026424B2 (es) |
CN (4) | CN104622789A (es) |
AU (2) | AU2011323524B2 (es) |
CA (1) | CA2816576C (es) |
HK (3) | HK1210048A1 (es) |
IN (1) | IN2013MN00758A (es) |
RU (1) | RU2640918C2 (es) |
TW (1) | TWI615150B (es) |
WO (1) | WO2012061377A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
EP2427179A4 (en) | 2009-05-04 | 2013-09-11 | Psivida Inc | POROUS PARTICLES FOR THE RELEASE OF SILICIUM MEDICINES |
IN2013MN00758A (es) | 2010-11-01 | 2015-06-12 | Psivida Inc | |
CA2904204A1 (en) * | 2013-03-12 | 2014-10-09 | Psivida Us, Inc. | Drug delivery device comprising silicon-based carrier particles |
US20140271764A1 (en) * | 2013-03-12 | 2014-09-18 | Psivida Us, Inc. | Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents |
JP2016512839A (ja) * | 2013-03-15 | 2016-05-09 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 治療物質の送達のための生体内分解性ケイ素系組成物 |
WO2016044366A1 (en) * | 2014-09-16 | 2016-03-24 | Psivida Us, Inc. | Compositions and methods for controlled release of agents |
JP6883257B2 (ja) * | 2017-05-16 | 2021-06-09 | 株式会社豊田中央研究所 | 還元反応用固体触媒 |
CN112672732A (zh) | 2018-06-19 | 2021-04-16 | 细胞疗法有限责任公司 | 包含神经营养剂、凋亡信号传导片段抑制剂(FAS)或FAS配体(FASL)抑制剂、肿瘤坏死因子-α(TNF-α)或TNF受体抑制剂、线粒体肽、寡核苷酸、趋化因子抑制剂或半胱氨酸-天冬氨酸蛋白酶的药物递送系统 |
EP3810082A1 (en) | 2018-06-19 | 2021-04-28 | Cella Therapeutics, LLC | Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a cnp compound, an npr-b compound, a tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension |
TWI803092B (zh) * | 2021-04-01 | 2023-05-21 | 逢甲大學 | 具負載與釋放活性成分的奈米粒子、其製造方法與眼用裝置之應用 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3832458A (en) | 1971-12-06 | 1974-08-27 | River C Foundation | Hydrophilic silicone composition and method |
US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
US3919723A (en) | 1974-05-20 | 1975-11-18 | Friedrichsfeld Gmbh | Bone shaft or bone joint prosthesis and process |
US3919060A (en) | 1974-06-14 | 1975-11-11 | Ibm | Method of fabricating semiconductor device embodying dielectric isolation |
DE3214667C2 (de) | 1982-04-21 | 1985-07-18 | Akzo Gmbh, 5600 Wuppertal | Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen |
JPS59101145A (ja) | 1982-11-30 | 1984-06-11 | 日本特殊陶業株式会社 | 薬液含浸多孔質セラミツクス |
JPS59131346A (ja) | 1983-01-17 | 1984-07-28 | 日本特殊陶業株式会社 | 薬液含浸多孔質セラミツクスの製造法 |
DE3423667A1 (de) | 1984-05-08 | 1985-11-28 | Rüdiger Dipl.-Ing. 5204 Lohmar Scheunemann | Implantat fuer knochen- und zahnwurzelersatz mit spezieller uebergangsstruktur zwischen knochen und implantatkern und knochenseitig ganz oder teilweise resorbierbarer matrix |
GB8422876D0 (en) | 1984-09-11 | 1984-10-17 | Secr Defence | Silicon implant devices |
US4608048A (en) | 1984-12-06 | 1986-08-26 | Alza Corporation | Dispensing device with drug delivery patterns |
US5057082A (en) | 1988-11-04 | 1991-10-15 | Plastic Injectors, Inc. | Trocar assembly |
WO1990011070A1 (en) | 1989-03-17 | 1990-10-04 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
US5167625A (en) | 1990-10-09 | 1992-12-01 | Sarcos Group | Multiple vesicle implantable drug delivery system |
NZ247392A (en) * | 1992-04-30 | 1995-05-26 | Takeda Chemical Industries Ltd | Prefilled syringe containing two substances mixed before injection |
US5366454A (en) | 1993-03-17 | 1994-11-22 | La Corporation De L'ecole Polytechnique | Implantable medication dispensing device |
US5370630A (en) | 1993-11-12 | 1994-12-06 | Smidebush; Michael J. | Device for injection of fluidic materials into body tissue |
US5489266A (en) * | 1994-01-25 | 1996-02-06 | Becton, Dickinson And Company | Syringe assembly and method for lyophilizing and reconstituting injectable medication |
US5558071A (en) | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
US5817327A (en) | 1994-07-27 | 1998-10-06 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US5591453A (en) | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US5665114A (en) | 1994-08-12 | 1997-09-09 | Meadox Medicals, Inc. | Tubular expanded polytetrafluoroethylene implantable prostheses |
US5792099A (en) | 1995-02-14 | 1998-08-11 | Decamp; Dennis | Syringe and cannula for insertion of viscoelastic material into an eye and method of using same |
CA2216934A1 (en) | 1995-04-03 | 1996-10-10 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
US6096344A (en) | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
US5665428A (en) | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
DE19608423A1 (de) | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Implantate mit phasenweiser Arzneistoffabgabe |
FR2749169B1 (fr) * | 1996-06-04 | 1998-08-21 | Delab | Procede pour constituer une preparation injectable et dispositif pour la mise en oeuvre de ce procede |
US7070590B1 (en) | 1996-07-02 | 2006-07-04 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5922299A (en) | 1996-11-26 | 1999-07-13 | Battelle Memorial Institute | Mesoporous-silica films, fibers, and powders by evaporation |
JP3217286B2 (ja) * | 1996-12-19 | 2001-10-09 | 科学技術振興事業団 | Dna固定化複合体 |
US6696258B1 (en) | 1998-01-20 | 2004-02-24 | Drexel University | Mesoporous materials and methods of making the same |
WO1999036357A1 (en) | 1998-01-20 | 1999-07-22 | Drexel University | Mesoporous materials and methods of making the same |
US6060036A (en) | 1998-02-09 | 2000-05-09 | Implant Sciences Corporation | Radioactive seed implants |
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
GB9815819D0 (en) | 1998-07-22 | 1998-09-16 | Secr Defence | Transferring materials into cells and a microneedle array |
CA2355860C (en) | 1998-12-23 | 2010-03-30 | Alza Corporation | Dosage forms comprising porous particles |
WO2000040089A1 (en) * | 1999-01-05 | 2000-07-13 | Massachusetts Eye And Ear Infirmary | Targeted transscleral controlled release drug delivery to the retina and choroid |
AU7881000A (en) | 1999-08-16 | 2001-03-13 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
GB9924334D0 (en) | 1999-10-15 | 1999-12-15 | Secr Defence | Pharmaceutical products and methods of fabrication therefor |
CA2387925A1 (en) | 1999-10-18 | 2001-04-26 | Ferx Incorporated | Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
SE9903958D0 (sv) | 1999-11-02 | 1999-11-02 | Boerje Sellergren | Porous materials for selective binding or transport of molecular guests |
US6521284B1 (en) | 1999-11-03 | 2003-02-18 | Scimed Life Systems, Inc. | Process for impregnating a porous material with a cross-linkable composition |
AUPQ573300A0 (en) | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
DK1278518T3 (da) | 2000-02-28 | 2007-01-15 | Pfizer Entpr Sarl | Synergistisk kombination til behandling af colorektal cancer |
IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
AU2001252201A1 (en) | 2000-03-14 | 2001-09-24 | Amylin Pharmaceuticals, Inc. | Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
GB0008494D0 (en) * | 2000-04-07 | 2000-05-24 | Secr Defence | Microprojectile delivery system |
GB2365769A (en) | 2000-08-18 | 2002-02-27 | Secr Defence | Skin preparations containing silicon |
GB0104383D0 (en) | 2001-02-22 | 2001-04-11 | Psimedica Ltd | Cancer Treatment |
US6973718B2 (en) | 2001-05-30 | 2005-12-13 | Microchips, Inc. | Methods for conformal coating and sealing microchip reservoir devices |
JP2005536625A (ja) | 2002-08-23 | 2005-12-02 | マクマスター ユニバーシティー | ポリオール修飾シラン由来シリカの形態および収縮を制御する方法および化合物 |
ES2400852T3 (es) | 2002-09-18 | 2013-04-12 | Allergan Inc. | Aparato para el aporte de implantes oculares |
WO2004071949A2 (en) | 2003-02-13 | 2004-08-26 | The Regents Of The University Of California | Nanostructured casting of organic and bio-polymers in porous silicon templates |
US7433811B2 (en) | 2003-05-06 | 2008-10-07 | The Regents Of The University Of California | Direct patterning of silicon by photoelectrochemical etching |
US7563451B2 (en) | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
EP1694307A2 (en) | 2003-10-21 | 2006-08-30 | PSIMEDICA Limited | Methods for the treatment of cancer |
GB0324483D0 (en) | 2003-10-21 | 2003-11-19 | Psi Medica Ltd | Composite material |
US20050181049A1 (en) | 2003-11-19 | 2005-08-18 | Dong Liang C. | Composition and method for enhancing bioavailability |
MX2007003280A (es) | 2004-09-17 | 2007-05-24 | Ormco Corp | Aparato de tratamiento medico y metodo de manufactura de aguja. |
WO2006039333A1 (en) | 2004-09-30 | 2006-04-13 | Bausch & Lomb Incorporated | Ophthalmic drug release device for multiple drug release |
WO2006037160A1 (en) * | 2004-10-05 | 2006-04-13 | The University Of Melbourne | Porous polyelectrolyte materials |
WO2006050221A2 (en) | 2004-10-29 | 2006-05-11 | The Regents Of The University Of California | Porous photonic crystals for drug delivery to the eye |
WO2006067979A1 (ja) | 2004-12-21 | 2006-06-29 | Nec Corporation | フィルム外装電気デバイス用ケース |
JP2007091716A (ja) | 2005-08-29 | 2007-04-12 | Kuraray Co Ltd | 水中薬剤徐放性微粒子及びその製造方法 |
GB0526332D0 (en) | 2005-12-23 | 2006-02-01 | Psimedica Ltd | Pharmaceutical product |
JP2009529888A (ja) * | 2006-03-14 | 2009-08-27 | ユニバーシティ オブ ロチェスター | 超薄多孔質メンブレンを有する細胞培養装置およびその使用 |
NZ572193A (en) | 2006-03-31 | 2011-10-28 | Quadra Logic Tech Inc | Nasolacrimal drainage system implants for drug therapy with non-fluid swellable retention structure around drug core |
JP4984644B2 (ja) * | 2006-05-19 | 2012-07-25 | 株式会社ジェイ・エム・エス | 注射装置 |
US9248121B2 (en) * | 2006-08-21 | 2016-02-02 | Abbott Laboratories | Medical devices for controlled drug release |
BRPI0717171B1 (pt) | 2006-09-25 | 2023-10-17 | Archer Daniels Midland Company | Material superabsorvente |
JP5141948B2 (ja) * | 2007-07-09 | 2013-02-13 | 株式会社豊田中央研究所 | バイモダルな細孔構造を有する球状シリカ系メソ多孔体及びその製造方法 |
CN101815504B (zh) * | 2007-07-10 | 2013-11-20 | 加利福尼亚大学董事会 | 用于向所选择组织递送组合物的材料和方法 |
US20130084243A1 (en) | 2010-01-27 | 2013-04-04 | Liliane Goetsch | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
EP2889029A1 (en) | 2008-09-25 | 2015-07-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
GB0817938D0 (en) | 2008-09-30 | 2008-11-05 | Intrinsiq Materials Global Ltd | Cosmetic formulations |
GB0817936D0 (en) * | 2008-09-30 | 2008-11-05 | Intrinsiq Materials Global Ltd | Porous materials |
JP5369725B2 (ja) | 2009-01-30 | 2013-12-18 | 株式会社ニコン | 撮像装置 |
US20120045515A1 (en) * | 2009-02-04 | 2012-02-23 | Ye Liu | Hollow silica particle with a polymer thereon |
US20110300222A1 (en) | 2009-02-20 | 2011-12-08 | The Regents Of The University Of California | Luminescent porous silicon nanoparticles, methods of making and using same |
WO2010111627A1 (en) | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
JP5382700B2 (ja) * | 2009-03-27 | 2014-01-08 | 独立行政法人産業技術総合研究所 | ロッド状多孔質シリカ粒子 |
EP2427179A4 (en) | 2009-05-04 | 2013-09-11 | Psivida Inc | POROUS PARTICLES FOR THE RELEASE OF SILICIUM MEDICINES |
US20110028412A1 (en) | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
GB201017048D0 (en) | 2010-10-08 | 2010-11-24 | Ucl Business Plc | Composition |
IN2013MN00758A (es) | 2010-11-01 | 2015-06-12 | Psivida Inc | |
WO2012088304A2 (en) | 2010-12-22 | 2012-06-28 | Psivida Us, Inc. | Two-piece injectable drug delivery device with heat-cured seal |
CA2827082A1 (en) | 2011-02-11 | 2012-08-16 | Psivida Us, Inc. | Methods of treating macular edema using antiedema therapeutics |
CA2830654A1 (en) | 2011-03-31 | 2012-10-04 | Galderma Research & Development | Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material |
CN103889401B (zh) | 2011-08-29 | 2017-10-13 | Qlt公司 | 持续释放递送活性剂以治疗青光眼和高眼压 |
KR20150085078A (ko) | 2012-11-21 | 2015-07-22 | 아지오스 파마슈티컬스 아이엔씨. | 글루타마제 억제제 및 사용 방법 |
US20140271764A1 (en) | 2013-03-12 | 2014-09-18 | Psivida Us, Inc. | Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents |
US10517844B2 (en) | 2014-11-13 | 2019-12-31 | Buck Institute For Research On Aging | Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications |
-
2011
- 2011-11-01 IN IN758MUN2013 patent/IN2013MN00758A/en unknown
- 2011-11-01 US US13/286,788 patent/US9333173B2/en active Active
- 2011-11-01 TW TW100139841A patent/TWI615150B/zh not_active IP Right Cessation
- 2011-11-01 CA CA2816576A patent/CA2816576C/en not_active Expired - Fee Related
- 2011-11-01 CN CN201410826616.4A patent/CN104622789A/zh active Pending
- 2011-11-01 AU AU2011323524A patent/AU2011323524B2/en not_active Ceased
- 2011-11-01 WO PCT/US2011/058774 patent/WO2012061377A1/en active Application Filing
- 2011-11-01 RU RU2013119438A patent/RU2640918C2/ru active
- 2011-11-01 CN CN201180056566.0A patent/CN103282020B/zh active Active
- 2011-11-01 JP JP2013536924A patent/JP6026424B2/ja not_active Expired - Fee Related
- 2011-11-01 EP EP11838672.1A patent/EP2635255B1/en active Active
- 2011-11-01 CN CN201410827969.6A patent/CN104622790A/zh active Pending
- 2011-11-01 CN CN201410822342.1A patent/CN104586742A/zh active Pending
-
2015
- 2015-11-06 HK HK15110964.4A patent/HK1210048A1/xx unknown
- 2015-11-12 HK HK15111163.1A patent/HK1210416A1/xx unknown
- 2015-11-12 HK HK15111162.2A patent/HK1210415A1/xx unknown
-
2016
- 2016-02-04 JP JP2016019772A patent/JP6189460B2/ja not_active Expired - Fee Related
- 2016-05-05 US US15/147,203 patent/US11026885B2/en active Active
- 2016-10-20 US US15/299,050 patent/US9808421B2/en active Active
- 2016-11-16 AU AU2016259330A patent/AU2016259330B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US11026885B2 (en) | 2021-06-08 |
HK1210415A1 (en) | 2016-04-22 |
US9333173B2 (en) | 2016-05-10 |
WO2012061377A1 (en) | 2012-05-10 |
CA2816576A1 (en) | 2012-05-10 |
JP6026424B2 (ja) | 2016-11-16 |
AU2011323524A1 (en) | 2013-05-23 |
CN104586742A (zh) | 2015-05-06 |
TW201306867A (zh) | 2013-02-16 |
CN104622789A (zh) | 2015-05-20 |
EP2635255A1 (en) | 2013-09-11 |
CN103282020B (zh) | 2016-10-26 |
RU2013119438A (ru) | 2014-12-10 |
JP6189460B2 (ja) | 2017-08-30 |
TWI615150B (zh) | 2018-02-21 |
JP2016121173A (ja) | 2016-07-07 |
US9808421B2 (en) | 2017-11-07 |
HK1210416A1 (en) | 2016-04-22 |
CN103282020A (zh) | 2013-09-04 |
AU2016259330A1 (en) | 2016-12-08 |
US20120177695A1 (en) | 2012-07-12 |
RU2640918C2 (ru) | 2018-01-12 |
HK1210048A1 (en) | 2016-04-15 |
JP2013541562A (ja) | 2013-11-14 |
US20170035690A1 (en) | 2017-02-09 |
EP2635255A4 (en) | 2016-11-09 |
EP2635255B1 (en) | 2019-08-21 |
CN104622790A (zh) | 2015-05-20 |
AU2011323524B2 (en) | 2016-12-08 |
CA2816576C (en) | 2020-06-02 |
AU2016259330B2 (en) | 2018-11-08 |
US20160243276A1 (en) | 2016-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MN00758A (es) | ||
CY1119192T1 (el) | Μεθοδος κρυσταλλωσης και βιοδιαθεσιμοτητα | |
MX2020002118A (es) | Oligómeros antisentido para tratamiento de afecciones y enfermedades. | |
GB2465677B (en) | Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes | |
NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
EP3192526A3 (en) | Exosomes for delivery of biotherapeutics | |
EP1971288A4 (en) | MICRONIZED DEVICE FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHOD OF USE | |
IL211952A0 (en) | Implantable device for the delivery of risperidone and methods of use thereof | |
MX354444B (es) | Dispositivos implantables heterogeneos para suministro de medicamento. | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
MX339125B (es) | Endoprotesis de metal desnudo con receptaculos eluyentes de farmacos. | |
EP2406379A4 (en) | COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA | |
MX337614B (es) | Tratamiento de lupus nefritis usando laquinimod. | |
PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
UA108885C2 (uk) | Композиція рисперидону для ін'єкційної депо-форми | |
MX340636B (es) | Dispositivo oftalmico que tiene capacidad de liberacion de agentes terapeuticos y metodos para formar el mismo. | |
BR112013000841A2 (pt) | composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano. | |
MX352824B (es) | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación. | |
IL210545A (en) | Transplantation devices for use of octreotide transport and use of octreotide to create drugs | |
WO2012037519A3 (en) | Acceleration of wound healing by growth hormone releasing hormone and its agonists | |
PL2768312T3 (pl) | Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości | |
MX367070B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. | |
MX2014001393A (es) | 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas. | |
MX2015011775A (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
MX351282B (es) | Stent de metal sin recubrir con depósitos de elución de fármaco que tiene retención de fármaco mejorada. |